ADMINISTRATION OF A GONADOTROPIN-RELEASING-HORMONE AGONIST DURING PREGNANCY - FOLLOW-UP OF 28 PREGNANCIES EXPOSED TO TRIPTORELINE

被引:26
作者
ELEFANT, E [1 ]
BIOUR, B [1 ]
BLUMBERGTICK, J [1 ]
ROUX, C [1 ]
THOMAS, F [1 ]
机构
[1] IPSEN BIOTECH INC,TIPTORELINE,PARIS,FRANCE
关键词
GNRH AGONIST; PREGNANCY; TERATOGENICITY;
D O I
10.1016/S0015-0282(16)57557-8
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Objective: To evaluate the teratogenic or fetal risk of a long-acting GnRH agonist (GnRH-a) triptoreline acetate (Decapeptyl; Ipsen-Biotech, Inc., Paris, France), inadvertently administrated in the first weeks of pregnancy. Design: Prospective follow-up of exposed pregnancies and case reports. Setting: Teratology information service of a public hospital and pharmacovigilance department of the firm. Patients: Inadvertent pregnant women receiving a treatment, mainly for endometriosis or IVF. Interventions: Case by case, individual estimations of the risks have been provided. Main Outcome Measure: Each pregnancy issue has been analyzed. Results: No teratogenic or fetal toxic effect has been noted. Conclusion: No specific hazard has been observed among newborns after inadvertent exposures to a GnRH-a during the first 20 weeks of pregnancy.
引用
收藏
页码:1111 / 1113
页数:3
相关论文
共 5 条
  • [1] DRIEU K, 1989, CONTRACEPT FERTIL S, V17, P1105
  • [2] TERATOGENIC AGENT INFORMATION-CENTER - 15 YEARS OF COUNSELING AND PREGNANCY FOLLOW-UP
    ELEFANT, E
    BOYER, M
    BOYER, P
    GALLIOT, B
    ROUX, C
    [J]. TERATOLOGY, 1992, 46 (01) : 35 - 44
  • [3] CASE-REPORT - ACCIDENTAL GNRH AGONIST ADMINISTRATION DURING EARLY-PREGNANCY
    MARTINEZ, F
    BARRI, PN
    COROLEU, V
    [J]. HUMAN REPRODUCTION, 1988, 3 (05) : 669 - 669
  • [4] WILSHIRE GB, 1993, FERTIL STERIL, V60, P980
  • [5] YOUNG DC, 1993, OBSTET GYNECOL, V81, P587